Revised Guidelines on Data Integrity and Validation of Computerised Systems
Moscow, the Eurasian Economic Commission (EEC) working group on common approaches to pharmaceutical regulation within the Eurasian Economic Union has adopted the guidelines “Data integrity and validation of computerised systems” at the second reading, after the completion of the public discussion.
The guidelines were elaborated by the experts of the FSI “State Institute of Drugs and Good Practices”, Russian Ministry of Industry and Trade, with the support of the PQE company (Italy) and submitted to the EEC working group by the ISPE Eurasian Economic Union Affiliate. After certain technical procedures are completed, the EEC administration will adopt the guidelines as EEC Recommendations.
Following the results of the first reading, during the public discussion, the Association of Clinical Trials Organisations and expert community offered a number of suggestions related mainly to the application of the Guidelines beyond the spheres regulated by the GMP rules. After revision by the authoring team, the EEC working group approved a version of the Guidelines that can be voluntarily used in other areas of good practices (GxP): GDP, GCP, GLP, and GVP, as well as other related areas, such as drug quality control laboratories.
The unanimous adoption of the Guidelines by the EEC Working Group in an unprecedentedly short time with a minimal number of revisions and comments indicates both the high level of preparation of the document and the high level of interest of the industry.
The final English version will be available after the adoption of the EEC Recommendation.
- Cooperation issues in the pharmaceutical industry and healthcare system were discussed at the Russia-Africa Summit
- International cooperation discussed at the Drug Safety Forum
- Transformation of medical education and training of highly qualified personnel discussed at the Uzbek-Russian Medical Forum
- Memorandum of Cooperation signed between the Eurasian Academy of Good Practices, State Center for Expertise and Standardization of Medicines, Medical Devices and Medical Equipment (Uzbekistan), and Rusatom Healthcare JSC
- The prospects for the development of cooperation between Russia and Saudi Arabia in the pharmaceutical industry were discussed as part of the business mission Made in Russia + INNOPROM